The safety evaluation of food flavoring substances: the role of genotoxicity studies

References

• Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, et al. 2004. The FEMA GRAS assessment of cinnamyl derivatives used as flavor ingredients. Food Chem Toxicol. 42(2):157–185.
   PubMed Web of Science ®Google Scholar
• Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, et al. 2005a. The FEMA GRAS assessment of benzyl derivatives used as flavor ingredients. Food Chem Toxicol. 43(8):1207–1240.
   PubMed Web of Science ®Google Scholar
• Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, et al. 2005b. The FEMA GRAS assessment of hydroxy- and alkoxy-substituted benzyl derivatives used as flavor ingredients. Food Chem Toxicol. 43(8):1241–1271.
   PubMed Web of Science ®Google Scholar
• Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, et al. 2005c. The FEMA GRAS assessment of phenethyl alcohol, aldehyde, acid, and related acetals and esters used as flavor ingredients. Food Chem Toxicol. 43(8):1179–1206.
   PubMed Web of Science ®Google Scholar
• Adams TB, Doull J, Goodman JI, Munro IC, Newberne P, Portoghese PS, Smith RL, Wagner BM, Weil CS, Woods LA, et al. 1997. The FEMA GRAS assessment of furfural used as a flavour ingredient. Food Chem Toxicol. 35(8):739–751.
   PubMed Web of Science ®Google Scholar
• Adams TB, Gavin CL, McGowen MM, Waddell WJ, Cohen SM, Feron VJ, Marnett LJ, Munro IC, Portoghese PS, Rietjens IMCM, et al. 2011. The FEMA GRAS assessment of aliphatic and aromatic terpene hydrocarbons used as flavor ingredients. Food Chem Toxicol. 49(10):2471–2494.
   PubMed Web of Science ®Google Scholar
• Adams TB, Gavin CL, Taylor SV, Waddell WJ, Cohen SM, Feron VJ, Goodman JI, Rietjens IMCM, Marnett LJ, Portoghese PS, et al. 2008. The FEMA GRAS assessment of alpha, beta-unsaturated aldehydes and related substances used as flavor ingredients. Food Chem Toxicol. 46(9):2935–2967.
   PubMed Web of Science ®Google Scholar
• Adams TB, Greer DB, Doull J, Munro IC, Newberne P, Portoghese PS, Smith RL, Wagner BM, Weil CS, Woods LA, et al. 1998. The FEMA GRAS assessment of lactones used as flavour ingredients. Food Chem Toxicol. 36(4):249–278.
   PubMed Web of Science ®Google Scholar
• Adams TB, Hallagan JB, Putnam JM, Gierke TL, Doull J, Munro IC, Newberne P, Portoghese PS, Smith RL, Wagner BM, et al. 1996. The FEMA GRAS assessment of alicyclic substances used as flavour ingredients. Food Chem Toxicol. 34(9):763–828.
   PubMed Web of Science ®Google Scholar
• Adams TB, McGowen MM, Williams MC, Cohen SM, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, et al. 2007. The FEMA GRAS assessment of aromatic substituted secondary alcohols, ketones, and related esters used as flavor ingredients. Food Chem Toxicol. 45(2):171–201.
   PubMed Web of Science ®Google Scholar
• Alhusainy W, Williams GM, Jeffrey AM, Iatropoulos MJ, Taylor S, Adams TB, Rietjens IMCM. 2014. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat. Food Chem Toxicol. 74:28–34.
   PubMed Web of Science ®Google Scholar
• Al-Subeihi AAA, Spenkelink B, Punt A, Boersma MG, van Bladeren PJ, Rietjens IMCM. 2012. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat. Toxicol Appl Pharmacol. 260(3):271–284.
   PubMed Web of Science ®Google Scholar
• Balbo S, Hashibe M, Gundy S, Brennan P, Canova C, Simonato L, Merletti F, Richiardi L, Agudo A, Castellsague X, et al. 2008. N2-ethyldeoxyguanosine as a potential biomarker for assessing effects of alcohol consumption on DNA. Cancer Epidemiol Biomark Prev. 17(11):3026–3032.
   PubMed Web of Science ®Google Scholar
• Balbo S, Meng L, Bliss RL, Jensen JA, Hatsukami DK, Hecht SS. 2012. Kinetics of DNA adduct formation in the oral cavity after drinking alcohol. Cancer Epidemiol Biomark Prev. 21(4):601–608.
   PubMed Web of Science ®Google Scholar
• Barlow S, Schlatter J. 2010. Risk assessment of carcinogens in food. Toxicology and Applied Pharmacology. 243(2):180–190.
   PubMed Web of Science ®Google Scholar
• Barnes JL, Zubair M, John K, Poirier MC, Martin FL. 2018. Carcinogens and DNA damage. Biochem Soc Trans. 46(5):1213–1224.
   PubMedGoogle Scholar
• Bartsch H, Ohshima H, Pignatelli B, Calmels S. 1992. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics. 2(6):272–277.
   PubMedGoogle Scholar
• Basu AK. 2018. DNA damage, mutagenesis and cancer. IJMS. 19(4):970.
   Google Scholar
• Bhagat J. 2018. Combinations of genotoxic tests for the evaluation of group 1 IARC carcinogens. J Appl Toxicol. 38:81–99.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Brown P, Cronin MTD, Edwards J, Galli CL, Goodman JI, Jacobs A, Kirkland D, Luijten M, Marsaux C, et al. 2017. Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation. Crit Rev Toxicol. 47(8):710–732.
   Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco VL, Doe JE, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC. 2016. Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society. Regul Toxicol Pharmacol. 82:158–166.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Doerrer NG, Galloway SM, Haley PJ, Hard GC, Hess FG, Macdonald JS, Thibault S, Wolf DC, et al. 2009. A data-based assessment of alternative strategies for identification of potential human cancer hazards. Toxicol Pathol. 37(6):714–732.
   PubMed Web of Science ®Google Scholar
• Bowen R. 2011. Reverse mutation in five histidine-requiring strains of Salmonella typhimurium. Furan-2(5H)-one. Covance Laboratories Ltd. Study no. 8233099. September 2011. Unpublished report submitted by EFFA to FLAVIS Secretariat.
   Google Scholar
• Broustas CG, Lieberman HB. 2014. DNA damage response genes and the development of cancer metastasis. Radiat Res. 181(2):111–130.
   PubMed Web of Science ®Google Scholar
• Brusick D. 1986. Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen. 8(6):879–886.
   PubMedGoogle Scholar
• Brusick DJ. 1987. Implications of treatment-condition-induced genotoxicity for chemical screening and data interpretation. Mutat Res. 189(1):1–6.
   PubMedGoogle Scholar
• Caldwell J. 1987. Human disposition of 14C-ORP/178. Unpublished report provided to the Expert Panel of the Flavor and Extract Manufacturers Association, Washington, DC, USA.
   Google Scholar
• Cohen SM. 2004. Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay. Toxicol Sci. 80(2):225–229.
   PubMed Web of Science ®Google Scholar
• Cohen SM. 2010. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors. Asian Pac J Cancer Prev. 11(1):15–17.
   PubMedGoogle Scholar
• Cohen SM. 2017. The relevance of experimental carcinogenicity studies to human safety. Curr Opin Toxicol. 3:6–11.
   Google Scholar
• Cohen SM, Arnold LL. 2016. Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J Toxicol Pathol. 29(4):215–227.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Eisenbrand G, Fukushima S, Gooderham NJ, Guengerich FP, Hecht SS, Rietjens IMCM, Bastaki M, Davidsen JM, Harman CL, et al. 2019. FEMA GRAS assessment of natural flavor complexes: citrus-derived flavoring ingredients. Food Chem Toxicol. 124:192–218.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Eisenbrand G, Fukushima S, Gooderham NJ, Guengerich FP, Hecht SS, Rietjens IMCM, Davidsen JM, Harman CL, Taylor SV. 2018. Updated procedure for the safety evaluation of natural flavor complexes used as ingredients in food. Food Chem Toxicol. 113:171–178.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Fukushima S, Gooderham NJ, Guengerich FP, Hecht FM, Rietjens IMCM, Smith LM, Bastaki M, Harman CG, McGowen MM, et al. 2017a. Safety evaluation of substituted thiophenes used as flavoring ingredients. Food Chem Toxicol. 99(99):40–59.
   PubMedGoogle Scholar
• Cohen SM, Fukushima S, Gooderham NJ, Guengerich FP, Hecht SS, Rietjens IMCM, Smith RL, Bastaki M, Harman CL, McGowen MM, et al. 2016. FEMA expert panel review of p-mentha-1,8-dien-7-al genotoxicity testing results. Food Chem Toxicol. 98(Part B):201–209.
   PubMedGoogle Scholar
• Cohen SM, Fukushima S, Guengerich FP, Gooderham NJ, Hecht SS, Rietjens IMCM, Smith RL. 2017b. GRAS flavoring substances 28. Washington, DC: Flavor & Extract Manufacturers Association.
   Google Scholar
• Cohen SM, Robinson D, MacDonald J. 2001. Forum: alternative models for carcinogenicity testing. Toxicol Sci. 64(1):14–19.
   PubMed Web of Science ®Google Scholar
• Cox JA, Fellows MD, Hashizume T, White PA. 2016. The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment. MUTAGE. 31(2):117–130.
   PubMed Web of Science ®Google Scholar
• Crespi CL, Gonzalez FJ, Steimel DT, Turner TR, Gelboin HV, Penman BW, Langenbach R. 1991. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem Res Toxicol. 4(5):566–572.
   PubMed Web of Science ®Google Scholar
• De Bont R, van Larebeke N. 2004. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis. 19(3):169–185.
   PubMed Web of Science ®Google Scholar
• Ding W, Levy DD, Bishop ME, Pearce MG, Davis KJ, Jeffrey AM, Duan JD, Williams GM, White GA, Lyn-Cook LE, et al. 2015. In vivo genotoxicity of estragole in male F344 rats. Environ Mol Mutagen. 56(4):356–365.
   PubMed Web of Science ®Google Scholar
• Doi AM, Hill G, Seely J, Hailey JR, Kissling G, Bucher JR. 2007. alpha2u-Globulin nephropathy and renal tumors in National Toxicology Program studies. Toxicol Pathol. 35(4):533–540.
   PubMed Web of Science ®Google Scholar
• Dubois M, De Waziers I, Thome JP, Kremers P. 1996. P450 induction by Aroclor 1254 and 3,3',4,4'-tetrachlorobiphenyl in cultured hepatocytes from rat, quail and man: interspecies comparison. Compar Biochem Physiol Part C, Pharmacol Toxicol Endocrinol. 113(1):51–59.
   PubMed Web of Science ®Google Scholar
• Dutta A. 2018. Furan-2(5H)-one: In vitro mammalian cell micronucleus assay in TK6 cells. Unpublished report provided by the International Organization of the Flavor Industry to the Expert Panel of the Flavor and Extract Manufacturers Association, Washington, DC, USA.
   Google Scholar
• Eder E, Scheckenbach S, Deininger C, Huffman C. 1993. The possible role of alpha, beta-unsaturated carbonyl compounds in mutagenesis and carcinogenesis. Toxicol Lett. 67(1–3):87–103.
   PubMed Web of Science ®Google Scholar
• EFSA. 2008a. Genotoxicity test strategy for substances belonging to subgroups of FGE.19 [1] - Statement of the panel on food contact materials, enzymes, flavourings and processing aids (CEF). EFSA J. 854:1–5.
   Google Scholar
• EFSA. 2008b. List of alpha, beta‐unsaturated aldehydes and ketones representative of FGE.19 substances for genotoxicity testing – statement of the panel on food contact materials, enzymes, flavourings and processing aids (CEF). EFSA J. 910:1–7.
   Google Scholar
• EFSA. 2011. Scientific Opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA J. 9(9):2379.
   Google Scholar
• EFSA. 2013a. Scientific Opinion on re-evaluation of one flavouring substance 3-acetyl-2, 5-dimethylthiophene [FL-no 15.024] from FGE.19 subgroup 52. EFSA J. 11(5):3227.
   Google Scholar
• EFSA. 2013b. Scientific Opinion on Flavouring Group Evaluation 217, Revision 1 (FGE.217Rev1). Consideration of genotoxic potential for α,β-unsaturated ketones and precursors from chemical subgroup 4.1 of FGE.19: lactones. EFSA J. 11(7):3304.
   Google Scholar
• EFSA. 2015a. Scientific Opinion on Flavouring Group Evaluation 99 Revision 1 (FGE.99Rev1): Consideration of furanone derivatives evaluated by the JECFA (63rd, 65th and 69th meetings). EFSA J. 13(11):4286.
   Web of Science ®Google Scholar
• EFSA. 2015b. Scientific Opinion on Flavouring Group Evaluation 220 Revision 3 (FGE.220Rev3): consideration of genotoxic potential for α,β‐unsaturated 3(2H)‐Furanones from subgroup 4.4 of FGE.19. EFSA J. 13(5):4117.
   Web of Science ®Google Scholar
• EFSA. 2016. Review of the Threshold of Toxicological Concern (TTC) approach and development of new TTC decision tree. EFSA Support Publ. 13(3):1–50.
   Google Scholar
• EFSA. 2017. Guidance on the use of the weight of evidence approach in scientific assessments. EFSA J. 15(8):e04971.
   Web of Science ®Google Scholar
• EFSA. 2019. Scientific Opinion on Flavouring Group Evaluation 217 Revision 2 (FGE.217Rev2), consideration of genotoxic potential for α,β-unsaturated ketones and precursors from chemical subgroup 4.1 of FGE.19: lactones. EFSA J. 17(1):5568.
   Web of Science ®Google Scholar
• Eisenbrand G, Schuhmacher J, Goelzer P. 1995. The influence of glutathione and detoxifying enzymes on DNA damage induced by 2-alkenals in primary rat hepatocytes and human lymphoblastoid cells. Chem Res Toxicol. 8(1):40–46.
   PubMed Web of Science ®Google Scholar
• Ellis JK, Carmichael PL, Gooderham NJ. 2007. Toxicological assessment of low dose exposure to the flour methyl eugenol. Unpublished report provided to the Expert Panel of the Flavor and Extract Manufacturers Association, Washington, DC, USA.
   Google Scholar
• EPA. 2004. An examination of EPA risk assessment principles and practices. Staff Paper Prepared for the U.S. Environmental Protection Agency by members of the Risk Assessment Task Force, Office of the Science Advisor, Washington DC. EPA/100/B-04/001, March 2004.
   Google Scholar
• EPA. 2005. Guidelines for carcinogen risk assessment. Risk Assessment Forum. U.S. Environmental Protection Agency Washington, DC. EPA/630/P-03/001B, March 2005.
   Google Scholar
• EU. 2009. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products.
   Google Scholar
• Fellows MD, O'Donovan MR. 2007. Cytotoxicity in cultured mammalian cells is a function of the method used to estimate it. Mutagenesis. 22(4):275–280.
   PubMed Web of Science ®Google Scholar
• Fellows M D, O’Donovan M R, Lorge E, Kirkland D. 2008. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. II: Practical aspects with toxic agents. Mutation Res. 655(1-2):4–21.
   PubMed Web of Science ®Google Scholar
• Foth H, Degen GH, Bolt HM. 2005. New aspects in the classification of carcinogens. Arh Hig Rada Toksikol. 56(2):167–175.
   PubMedGoogle Scholar
• Fowler P. 2014. Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. III: Sensitivity of human cell types to known genotoxic agents. Mutation Res. 767:28–36.
   PubMed Web of Science ®Google Scholar
• Fowler P, Smith K, Young J, Jeffrey L, Kirkland D, Pfuhler S, Carmichael P. 2012a. Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutation Res. 742:11–25
   PubMed Web of Science ®Google Scholar
• Fowler P, Smith R, Smith K, Young J, Jeffrey L, Kirkland D, Pfuhler S, Carmichael P. 2012b. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurement. Mutat Res. 747(1):104–117.
   PubMed Web of Science ®Google Scholar
• Frankel EN, Neff WE, Brooks DD, Fujimoto K. 1987. Fluorescence formation from the interaction of DNA with lipid oxidation degradation products. Biochim Biophys Acta (BBA) – Lipids Lipid Metab. 919(3):239–244.
   PubMedGoogle Scholar
• Fukushima S, Gi M, Fujioka M, Kakehashi A, Wanibuchi H, Matsumoto M. 2018. Quantitative Approaches to assess key carcinogenic events of genotoxic carcinogens. Toxicol Res. 34(4):291–296.
   PubMed Web of Science ®Google Scholar
• Galloway SM. 2000. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen. 35(3):191–201.
   PubMed Web of Science ®Google Scholar
• Gardner I, Bergin P, Stening P, Kenna JG, Caldwell J. 1996. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Chem Res Toxicol. 9(4):713–721.
   PubMed Web of Science ®Google Scholar
• Geacintov NE, Broyde S. 2017. Repair-resistant DNA lesions. Chem Res Toxicol. 30(8):1517–1548.
   PubMed Web of Science ®Google Scholar
• Glatt H. 2000. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact. 129(1-2):141–170.
   PubMed Web of Science ®Google Scholar
• Glatt H, Meinl W. 2005. Sulfotransferases and acetyltransferases in mutagenicity testing: technical aspects. Methods Enzymol. London: Academic Press; p. 230–249.
   Google Scholar
• Glatt H, Sabbioni G, Monien BH, Meinl W. 2016. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of human sulfotransferases in the bioactivation of nitro- and aminotoluenes. Environ Mol Mutagen. 57(4):299–311.
   PubMed Web of Science ®Google Scholar
• Glatt H, Schneider H, Murkovic M, Monien BH, Meinl W. 2012. Hydroxymethyl-substituted furans: mutagenicity in Salmonella typhimurium strains engineered for expression of various human and rodent sulphotransferases. Mutagenesis. 27(1):41–48.
   PubMed Web of Science ®Google Scholar
• Gocke E, Muller L. 2009. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutation Res. 678(2):101–107.
   PubMed Web of Science ®Google Scholar
• Hallagan J, Hall R. 1995. FEMA GRAS – a GRAS assessment program for flavor ingredients. Regul Toxicol Pharmacol. 21(3):422–430.
   PubMed Web of Science ®Google Scholar
• Hallagan J, Hall R. 2009. Under the conditions of intended use – new developments in the FEMA GRAS program and the safety assessment of flavor ingredients. Food Chem Toxicol. 47(2):267–278.
   PubMed Web of Science ®Google Scholar
• Hard GC. 2018. Mechanisms of rodent renal carcinogenesis revisited. Toxicol Pathol. 46(8):956–969. 192623318797071.
   PubMed Web of Science ®Google Scholar
• Hardy A, Benford D, Halldorsson T, Jeger M, Knutsen HK, More S, Naegeli H, Noteborn H, Ockleford C, Ricci A. 2017. Clarification of some aspects related to genotoxicity assessment. EFS2. 15(12):e05113.
   Web of Science ®Google Scholar
• Hecht SS. 2003. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3(10):733–744.
   PubMed Web of Science ®Google Scholar
• Hecht SS, McIntee EJ, Wang M. 2001. New DNA adducts of crotonaldehyde and acetaldehyde. Toxicology. 166(1-2):31–36.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Upadhyaya P, Wang M. 2011. Evolution of research on the DNA adduct chemistry of N-nitrosopyrrolidine and related aldehydes. Chem Res Toxicol. 24(6):781–790.
   PubMed Web of Science ®Google Scholar
• Hernandez LG, van Steeg H, Luijten M, van Benthem J. 2009. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutation Res. 682(2-3):94–109.
   PubMed Web of Science ®Google Scholar
• Herrmann K, Engst W, Appel KE, Monien BH, Glatt H. 2012. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods. Mutagenesis. 27(4):453–462.
   PubMed Web of Science ®Google Scholar
• Herrmann K, Engst W, Meinl W, Florian S, Cartus AT, Schrenk D, Appel KE, Nolden T, Himmelbauer H, Glatt H. 2014. Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2. Carcinogenesis. 35(4):935–941.
   PubMed Web of Science ®Google Scholar
• Herrmann K, Schumacher F, Engst W, Appel KE, Klein K, Zanger UM, Glatt H. 2013. Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples. Carcinogenesis. 34(5):1025–1030.
   PubMed Web of Science ®Google Scholar
• Hobbs CA, Taylor SV, Beevers C, Lloyd M, Bowen R, Lillford L, Maronpot R, Hayashi S-m. 2016. Genotoxicity assessment of the flavouring agent, perillaldehyde. Food Chem Toxicol. 97:232–242.
   PubMed Web of Science ®Google Scholar
• Holsapple MP, Pitot HC, Cohen SH, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP. 2006. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci. 89(1):51–56.
   PubMed Web of Science ®Google Scholar
• Honda H, Fujita Y, Kasamatsu T, Fuchs A, Fautz R, Morita O. 2018. Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices. Genes Environ. 40:2.
   PubMed Web of Science ®Google Scholar
• Honda H, Minegawa K, Fujita Y, Yamaguchi N, Oguma Y, Glatt H, Nishiyama N, Kasamatsu T. 2016. Modified Ames test using a strain expressing human sulfotransferase 1C2 to assess the mutagenicity of methyleugenol. Genes Environ. 38(1):1–5.
   PubMedGoogle Scholar
• Honma M. 2011. Cytotoxicity measurement in in vitro chromosome aberration test and micronucleus test. Mutation Res. 724(1-2):86–87.
   PubMed Web of Science ®Google Scholar
• Hummel JM, Madeen EP, Siddens LK, Uesugi SL, McQuistan T, Anderson KA, Turteltaub KW, Ognibene TJ, Bench G, Krueger SK, et al. 2018. Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: impact of co-administration of smoked salmon and BaP dietary restriction. Food Chem Toxicol. 115:136–147.
   PubMed Web of Science ®Google Scholar
• ILSI/HESI. 2001. ILSI/HESI alternatives to carcinogenicity testing project. Toxicol Pathol. 29(Supplement):1–351.
   PubMedGoogle Scholar
• Ishii Y, Suzuki Y, Hibi D, Jin M, Fukuhara K, Umemura T, Nishikawa A. 2011. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose. Chem Res Toxicol. 24(4):532–541.
   PubMed Web of Science ®Google Scholar
• JECFA. 1998a. 51st Joint FAO/WHO Expert Committee on Food Additives (JECFA) meeting – Food additives. WHO Technical Report Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• JECFA. 1998b. Safety evaluations of certiai food additives and contaminants WHO Food Additives Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• JECFA. 2005. 63rd Joint FAO/WHO Expert Committee on Food Additives (JECFA) meeting – Food additives. WHO Technical Report Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• JECFA. 2006. Safety evaluations of certain food additives and contaminants WHO Food Additives Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• JECFA. 2016. 82nd Joint FAO/WHO Expert Committee on Food Additives (JECFA) meeting – Food additives. WHO Technical Report Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• JECFA. 2019. 86th Joint FAO/WHO Expert Committee on Food Additives (JECFA) meeting – Food additives. WHO Technical Report Series. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Jia L, Liu X. 2007. The conduct of drug metabolism studies considered good practice (II): in vitro experiments. CDM. 8(8):822–829.
   Google Scholar
• Jin G, Cai L, Hu K, Luo Y, Chen Y, Glatt H, Liu Y. 2018. Mutagenic activity of N-nitrosodiethylamine in cell lines expressing human CYP2E1—adequacy of dimethylsulfoxide as solvent. Environ Mol Mutagen.
   Web of Science ®Google Scholar
• Kirkland D. 2011. Improvements in the reliability of in vitro genotoxicity testing. Expert Opin Drug Metab Toxicol. 7(12):1513–1520.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Aardema M, Henderson L, Müller L. 2005. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity. Mutation Res. 584(1-2):1–256.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Kasper P, Martus H-J, Müller L, van Benthem J, Madia F, Corvi R. 2016. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutation Res. 795:7–30.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, et al. 2007. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutation Res. 628(1):31–55.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Speit G. 2008. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. Mutation Res. 654(2):114–132.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Zeiger E, Madia F, Gooderham N, Kasper P, Lynch A, Morita T, Ouedraogo G, Parra Morte JM, Pfuhler S, et al. 2014. Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop. Mutation Res. 775–776:55–68.
   PubMed Web of Science ®Google Scholar
• Kiwamoto R, Rietjens IMCM, Punt A. 2012. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in rat. Chem Res Toxicol. 25(12):2630–2641.
   PubMed Web of Science ®Google Scholar
• Klapacz J, Pottenger LH, Engelward BP, Heinen CD, Johnson GE, Clewell RA, Carmichael PL, Adeleye Y, Andersen ME. 2016. Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents. Mutation Res Rev Mutation Res. 767:77–91.
   PubMed Web of Science ®Google Scholar
• Kobets T, Williams GM. 2016. Chapter 2 – Thresholds for hepatocarcinogenicity of DNA-reactive compounds. In: Nohmi T, Fukushima S, editors. Thresholds of genotoxic carcinogens. Boston: Academic Press; p. 19–36.
   Google Scholar
• Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos JG, et al. 2004. Structure-based Thresholds of Toxicological Concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol. 42(1):65–83.
   PubMed Web of Science ®Google Scholar
• Kurutas EB. 2015. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 15(1):71–71.
   Web of Science ®Google Scholar
• Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. 2007. Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N’-nitrosonornicotine. Chem Res Toxicol. 20(2):246–256.
   PubMed Web of Science ®Google Scholar
• Liu B, Xue Q, Tang Y, Cao J, Guengerich FP, Zhang H. 2016. Mechanisms of mutagenesis: DNA replication in the presence of DNA damage. Mutat Res Rev Mutat Res. 768:53–67.
   PubMed Web of Science ®Google Scholar
• Madeen E, Siddens LK, Uesugi S, McQuistan T, Corley RA, Smith J, Waters KM, Tilton SC, Anderson KA, Ognibene T, et al. 2019. Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing. Toxicol Appl Pharmacol. 364:97–105.
   PubMed Web of Science ®Google Scholar
• Marnett LJ, Cohen SM, Fukushima S, Gooderham NJ, Hecht SS, Rietjens IMCM, S R.L, Adams TB, H J.B, Harman C, et al. 2013. GRAS Flavoring Substances 26: The 26th publication by the Expert Panel of the Flavor and Extract Manufacturers Association provides an update on recent progress in the consideration of flavoring ingredients generally recognized as safe under the Food Additive Amendment. Food Technol. 67(8):38–56.
   Google Scholar
• Marnett LJ, Cohen SM, Fukushima S, Gooderham NJ, Hecht SS, Rietjens IMCM, Smith RL, Adams TB, Bastaki M, Harman CL, et al. 2014. GRASr2 evaluation of aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances used as flavoring ingredients. J Food Sci. 79(4):R428–R441.
   PubMed Web of Science ®Google Scholar
• Maronpot RR, Nyska A, Foreman JE, Ramot Y. 2016. The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms). Crit Rev Toxicol. 46(8):641–675.
   PubMed Web of Science ®Google Scholar
• McCullough AK, Lloyd RS. 2019. Mechanisms underlying aflatoxin-associated mutagenesis – Implications in carcinogenesis. DNA Repair. 77:76–86.
   PubMed Web of Science ®Google Scholar
• Miele M, Dondero R, Ciarallo G, Mazzei M. 2001. Methyleugenol in Ocimum basilicum L. Cv. Genovese Gigante. J Agric Food Chem. 49(1):517–521.
   PubMed Web of Science ®Google Scholar
• Monien BH, Schumacher F, Herrmann K, Glatt H, Turesky RJ, Chesné C. 2015. Simultaneous detection of multiple DNA adducts in human lung samples by isotope-dilution UPLC-MS/MS. Anal Chem. 87(1):641–648.
   PubMed Web of Science ®Google Scholar
• Morita T, Hamada S, Masumura K, Wakata A, Maniwa J, Takasawa H, Yasunaga K, Hashizume T, Honma M. 2016. Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens. Mutation Res/Genetic Toxicol Environ Mutagenesis. 802:1–29.
   PubMed Web of Science ®Google Scholar
• Morton D, Sistare FD, Nambiar PR, Turner OC, Radi Z, Bower N. 2014. Regulatory forum commentary: alternative mouse models for future cancer risk assessment. Toxicol Pathol. 42(5):799–806.
   PubMed Web of Science ®Google Scholar
• Nambiar PR, Turnquist SE, Morton D. 2012. Spontaneous tumor incidence in rasH2 Mice: review of internal data and published literature. Toxicol Pathol. 40(4):614–623.
   PubMed Web of Science ®Google Scholar
• Newberne P, Smith RL, Doull J, Goodman JI, Munro IC, Portoghese PS, Wagner BM, Weil CS, Woods LA, Adams TB, et al. 1999. The FEMA GRAS assessment of trans-anethole used as a flavouring substance. Food Chem Toxicol. 37(7):789–811.
   PubMed Web of Science ®Google Scholar
• Nohmi T. 2018. Thresholds of genotoxic and non-genotoxic carcinogens. ToxicolRes. 34(4):281–290.
   Google Scholar
• NTP. 2003. NTP Technical Report on the Carcinogenesis Studies of 2,4-hexadienal (CAS No 142-83-6) in F344/N Rats and B6C3F1. NTP TR 509 ed. Research Triangle Park, NC: NIH Publication No. 04-4443. National Toxicology Program.
   Google Scholar
• O'Donovan M. 2012. A critique of methods to measure cytotoxicity in mammalian cell genotoxicity assays. Mutagenesis. 27(6):615–621.
   PubMed Web of Science ®Google Scholar
• OECD. 1997. Test No. 471: Bacterial Reverse Mutation Test. OECD Publishing.
   Google Scholar
• OECD. 2013. Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. OECD Publishing.
   Google Scholar
• OECD. 2014. Test No. 489: In Vivo Mammalian Alkaline Comet Assay. OECD Publishing.
   Google Scholar
• OECD. 2016a. Test No. 473: In Vitro Mammalian Chromosomal Aberration Test.
   Google Scholar
• OECD. 2016b. Test No. 487: In Vitro Mammalian Cell Micronucleus Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264264861-en
   Google Scholar
• OECD. 2016c. Test No. 489: In Vivo Mammalian Alkaline Comet Assay.
   Google Scholar
• OECD. 2016d. Test No. 490: In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene.
   Google Scholar
• OECD. 2017. Overview on genetic toxicology TGs, OECD Series on Testing and Assessment, No. 238, Paris: OECD Publishing.
   Google Scholar
• Paini A, Punt A, Scholz G, Gremaud E, Spenkelink B, Alink G, Schilter B, van Bladeren PJ, Rietjens IMCM. 2012. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling. Mutagenesis. 27(6):653–663.
   PubMed Web of Science ®Google Scholar
• Paini A, Scholz G, Marin-Kuan M, Schilter B, O'Brien J, van Bladeren PJ, Rietjens IMCM. 2011. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays. Mutagenesis. 26(5):605–618.
   PubMed Web of Science ®Google Scholar
• Paranjpe MG, Elbekaei RH, Shah SA, Hickman M, Wenk ML, Zahalka EA. 2013. Historical control data of spontaneous tumors in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice. Int J Toxicol. 32(1):48–57.
   PubMed Web of Science ®Google Scholar
• Paranjpe MG, Shah SA, Denton MD, Elbekai RH. 2013. Incidence of spontaneous non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic mice. Toxicol Pathol. 41(8):1137–1145.
   PubMed Web of Science ®Google Scholar
• Patlewicz G, Wambaugh JF, Felter SP, Simon TW, Becker RA. 2018. Utilizing Threshold of Toxicological Concern (TTC) with high throughput exposure predictions (HTE) as a risk-based prioritization approach for thousands of chemicals. Computat Toxicol. 7:58–67.
   PubMedGoogle Scholar
• Peterson LA. 2017. Context matters: contribution of specific DNA adducts to the genotoxic properties of the tobacco-specific nitrosamine NNK. Chem Res Toxicol. 30(1):420–433.
   PubMed Web of Science ®Google Scholar
• Pfuhler S, Fellows M, van Benthem J, Corvi R, Curren R, Dearfield K, Fowler P, Frotschl R, Elhajouji A, Le H L, et al. 2011. In vitro genotoxicity test approaches with better predictivity: summary of an IWGT workshop. Mutation Res. 723(2):101–107.
   PubMed Web of Science ®Google Scholar
• Phillips DH, Reddy MV, Randerath K. 1984. 32 P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F 1 mice. Carcinogenesis. 5(12):1623–1628.
   PubMed Web of Science ®Google Scholar
• Pottenger LH, Boysen G, Brown K, Cadet J, Fuchs RP, Johnson GE, Swenberg JA. 2019. Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions. Environ Mol Mutagen. 60(2):100–121.
   PubMed Web of Science ®Google Scholar
• Povey AC. 2000. DNA adducts: endogenous and induced. Toxicol Pathol. 28(3):405–414.
   PubMed Web of Science ®Google Scholar
• Pratt IS, Barron T. 2003. Regulatory recognition of indirect genotoxicity mechanisms in the European Union. Toxicol Lett. 140-141:53–62.
   PubMed Web of Science ®Google Scholar
• Proctor DM, Gatto NM, Hong SJ, Allamneni KP. 2007. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol Sci. 98(2):313–326.
   PubMed Web of Science ®Google Scholar
• Punt A, Paini A, Boersma MG, Freidig AP, Delatour T, Scholz G, Schilter B, Bladeren PJv, Rietjens IMCM. 2009. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats. Toxicol Sci. 110(2):255–269.
   PubMed Web of Science ®Google Scholar
• Ramaiahgari SC, Waidyanatha S, Dixon D, DeVito MJ, Paules RS, Ferguson SS. 2017. From the cover: three-dimensional (3D) HepaRG Spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening. Toxicol Sci. 159(1):124–136.
   PubMed Web of Science ®Google Scholar
• Randerath K, Haglund RE, Phillips DH, Reddy MV. 1984. 32 P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis. 5(12):1613–1622.
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Bai A, Kulkarni AA, Moghaddam MF. 2016. Efficiency in drug discovery: liver S9 fraction assay as a screen for metabolic stability. DML. 10(2):83–90.
   Google Scholar
• Robinson DE, MacDonald JS. 2001. Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicologic Path. 29 (Suppl):13–19.
   PubMedGoogle Scholar
• Scott D, Galloway SM, Marshall RR, Ishidate M, Brusick D, Ashby J, Myhr BC. 1991. Genotoxicity under extreme culture conditions. Mutat Res/Rev Gen Toxicol. 257(2):147–205.
   PubMedGoogle Scholar
• Shah SA, Paranjpe MG, Atkins PI, Zahalka EA. 2012. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies. Int J Toxicol. 31(5):423–429.
   PubMed Web of Science ®Google Scholar
• Sistare F D, Morton D, Alden C, Christensen J, Keller D, Jonghe S D, Storer R D, Reddy M. V, Kraynak A, Trela B, et al. 2011. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol. 39(4):716–744.
   PubMed Web of Science ®Google Scholar
• Smith RL, Adams TB, Doull J, Feron VJ, Goodman JI, Marnett LJ, Portoghese PS, Waddell WJ, Wagner BM, Rogers AE, et al. 2002. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances — methyl eugenol and estragole. Food Chem Toxicol. 40(7):851–870.
   PubMed Web of Science ®Google Scholar
• Smith B, Cadby P, Leblanc JC, Setzer RW. 2010. Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: example: methyleugenol, CASRN: 93-15-2. Food Chem Toxicol. 48 (Suppl 1):S89–S97.
   PubMedGoogle Scholar
• Smith RL, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Waddell WJ, Wagner BM, et al. 2005. Criteria for the safety evaluation of flavoring substances. Food Chem Toxicol. 43(8):1141–1177.
   PubMed Web of Science ®Google Scholar
• Smith RL, Cohen SM, Fukushima S, Gooderham NJ, Hecht SS, Guengerich FP, Rietjens IMCM, Bastaki M, Harman CL, McGowen MM, et al. 2018. The safety evaluation of food flavouring substances: the role of metabolic studies. Toxicol Res. 7(4):618–646.
   Web of Science ®Google Scholar
• Smith RL, Waddell WJ, Cohen SM, Feron VJ, Marnett LJ, Portoghese PS, Rietjens IMCM, Adams TB, Lucas Gavin C, McGowen MM, et al. 2009. GRAS 24: the 24th publication by the FEMA Expert Panel presents safety and usage data on 236 new generally recognized as safe flavoring ingredients. Food Technol. 63(6):46–105.
   Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, et al. 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol. 34(2):146–152.
   PubMed Web of Science ®Google Scholar
• Speit G, Kojima H, Burlinson B, Collins AR, Kasper P, Plappert-Helbig U, Uno Y, Vasquez M, Beevers C, De Boeck M, et al. 2015. Critical issues with the in vivo comet assay: a report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT). Mutation Res Gen Toxicol Environ Mutagenesis. 783:6–12.
   PubMed Web of Science ®Google Scholar
• Swenberg JA, Lu K, Moeller BC, Gao L, Upton PB, Nakamura J, Starr TB. 2011. Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment. Toxicol Sci. 120(Supplement 1):S130–S145.
   PubMedGoogle Scholar
• Tornqvist M, Gustafsson B, Kautiainen A, Harms-Ringdahl M, Granath F, Ehrenberg L. 1989. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis. 10(1):39–41.
   PubMed Web of Science ®Google Scholar
• Tremmel R, Herrmann K, Engst W, Meinl W, Klein K, Glatt H, Zanger UM. 2017. Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels. Arch Toxicol. 91(10):3329–3339.
   PubMed Web of Science ®Google Scholar
• Tritscher AM. 2004. Human health risk assessment of processing-related compounds in food. Toxicol Lett. 149(1–3):177–186.
   PubMed Web of Science ®Google Scholar
• Urano K, Tamaoki N, Nomura T. 2012. Establishing a laboratory animal model from a transgenic animal: Rash2 mice as a model for carcinogenicity studies in regulatory science. Vet Pathol. 49(1):16–23.
   PubMed Web of Science ®Google Scholar
• Villalta PW, Hochalter JB, Hecht SS. 2017. Ultrasensitive high-resolution mass spectrometric analysis of a DNA adduct of the carcinogen Benzo[a]pyrene in human lung. Anal Chem. 89(23):12735–12742.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. 2013. Cancer genome landscapes. Science. 339(6127):1546–1558.
   PubMed Web of Science ®Google Scholar
• Wang M, Cheng G, Balbo S, Carmella SG, Villalta PW, Hecht SS. 2009. Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. Cancer Res. 69(18):7170–7174.
   PubMed Web of Science ®Google Scholar
• Wang M, McIntee EJ, Cheng G, Shi Y, Villalta PW, Hecht SS. 2000. Identification of DNA adducts of acetaldehyde. Chem Res Toxicol. 13(11):1149–1157.
   PubMed Web of Science ®Google Scholar
• Wang M, Yu N, Chen L, Villalta PW, Hochalter JB, Hecht SS. 2006. Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine. Chem Res Toxicol. 19(2):319–324.
   PubMed Web of Science ®Google Scholar
• Watters G. 2013. Furan-2(5H)-one: Induction of micronuclei in cultured human peripheral blood lymphocytes. Unpublished report provided by the International Organization of the Flavor Industry to the Expert Panel of the Flavor and Extract Manufacturers Association, Washington, DC, USA.
   Google Scholar
• Whitwell J. 2012. Furan-2(5H)-one: Induction of micronuclei in cultured human peripheral blood lymphocytes of furan-2(5H)-one. Unpublished report provided by the International Organization of the Flavor Industry to the Expert Panel of the Flavor and Extract Manufacturers Association, Washington, DC, USA.
   Google Scholar
• Whitwell J, Smith R, Jenner K, Lyon H, Wood D, Clements J, Aschcroft-Hawley K, Gollapudi B, Kirkland D, Lorge E, et al. 2015. Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: implications for improving existing assays. Mutation Res Gen Toxicol Environ Mutagenesis. 789–790:7–27.
   PubMed Web of Science ®Google Scholar
• Williams GM, Iatropoulos MJ, Jeffrey AM, Duan JD. 2013. Methyleugenol hepatocellular cancer initiating effects in rat liver. Food Chem Toxicol. 53:187–196.
   PubMed Web of Science ®Google Scholar
• Yager JD, Davidson NE. 2006. Estrogen carcinogenesis in breast cancer. N Engl J Med. 354(3):270–282.
   PubMed Web of Science ®Google Scholar
• Yang J, Balbo S, Villalta PW, Hecht SS. 2019. Analysis of acrolein-derived 1, N(2)-propanodeoxyguanosine adducts in human lung DNA from smokers and nonsmokers. Chem Res Toxicol. 32(2):318–325.
   PubMed Web of Science ®Google Scholar
• Zangouras A, Caldwell J, Hutt AJ, Smith RL. 1981. Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1-hydroxyestragole. Biochem Pharmacol. 30(11):1383–1386.
   PubMed Web of Science ®Google Scholar
• Zhang S, Villalta PW, Wang M, Hecht SS. 2006. Analysis of crotonaldehyde- and acetaldehyde-derived 1, n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol. 19(10):1386–1392.
   PubMed Web of Science ®Google Scholar